Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Polycythemia"" wg kryterium: Temat


Tytuł :
Evaluation of beta-2 microglobulin, erythropoietin and tobacco use in polycythemic cases.
Autorzy :
Mahe K; Hématologie Clinique, CH Cornouaille, Quimper, France.
Couturaud F; Département de Médecine Interne Et de Pneumologie, CHRU de Brest, Brest, France.; EA3878 GETBO, Groupe D'Etude de La Thrombose en Bretagne Occidentale, Brest, France.
Kerspern H; Laboratoire de Biochimie, CHRU de Brest, Brest, France.
Chauveau A; Laboratoire D'Hématologie, CHRU de Brest, Brest, France.; FIM, France Intergroupe Des Syndromes Myéloprolifératifs, Paris, France.
Ianotto JC; EA3878 GETBO, Groupe D'Etude de La Thrombose en Bretagne Occidentale, Brest, France. .; FIM, France Intergroupe Des Syndromes Myéloprolifératifs, Paris, France. .; Hématologie Clinique, Institut de Cancéro-Hématologie, CHRU de Brest, Brest, France. .
Pokaż więcej
Źródło :
International journal of hematology [Int J Hematol] 2021 Aug; Vol. 114 (2), pp. 222-227. Date of Electronic Publication: 2021 May 22.
Typ publikacji :
Journal Article
MeSH Terms :
Biomarkers*
Erythropoietin/*blood
Polycythemia/*blood
Polycythemia/*etiology
Tobacco Use/*adverse effects
beta 2-Microglobulin/*blood
Diagnosis, Differential ; Disease Susceptibility ; Humans ; Janus Kinase 2/genetics ; Mutation ; Polycythemia/diagnosis ; Polycythemia/epidemiology ; Polycythemia Vera/blood ; Polycythemia Vera/diagnosis ; Polycythemia Vera/etiology ; Prognosis
Czasopismo naukowe
Tytuł :
Management of hydroxyurea resistant or intolerant polycythemia vera.
Autorzy :
Raman I; Molecular Oncology and Cancer Immunology, Epworth Healthcare, Melbourne, Australia.; Walter and Eliza Hall Institute, Melbourne, Australia.
Pasricha SR; Walter and Eliza Hall Institute, Melbourne, Australia.
Prince HM; Molecular Oncology and Cancer Immunology, Epworth Healthcare, Melbourne, Australia.; Peter MacCallum Cancer Institute, Melbourne, Australia.
Yannakou CK; Molecular Oncology and Cancer Immunology, Epworth Healthcare, Melbourne, Australia.
Pokaż więcej
Źródło :
Leukemia & lymphoma [Leuk Lymphoma] 2021 Oct; Vol. 62 (10), pp. 2310-2319. Date of Electronic Publication: 2021 May 05.
Typ publikacji :
Journal Article
MeSH Terms :
Leukemia, Myeloid, Acute*
Polycythemia Vera*/diagnosis
Polycythemia Vera*/drug therapy
Thrombosis*
Humans ; Hydroxyurea/therapeutic use ; Phlebotomy
Czasopismo naukowe
Tytuł :
Mean corpuscular volume, hematocrit and polycythemia.
Autorzy :
Yavorkovsky LL; Oncology Division, Kaiser Permanente San Jose Medical Center, San Jose, CA, USA.
Pokaż więcej
Źródło :
Hematology (Amsterdam, Netherlands) [Hematology] 2021 Dec; Vol. 26 (1), pp. 881-884.
Typ publikacji :
Journal Article
MeSH Terms :
Hematocrit*
Erythrocytes/*pathology
Polycythemia/*pathology
Aged ; Erythrocyte Count ; Erythrocyte Indices ; Female ; Hemoglobins/analysis ; Humans ; Male ; Middle Aged ; Polycythemia/blood
Czasopismo naukowe
Tytuł :
High Risk Janus Kinase 2 V617F Allele Burden in a Seven-Year Cohort of Patients with Myeloproliferative Neoplasms.
Autorzy :
Chatambudza M
Skhosana L
Ketseoglou I
Wiggill T
Pokaż więcej
Źródło :
Clinical laboratory [Clin Lab] 2021 Nov 01; Vol. 67 (11).
Typ publikacji :
Journal Article
MeSH Terms :
Myeloproliferative Disorders*/diagnosis
Myeloproliferative Disorders*/genetics
Polycythemia Vera*/diagnosis
Polycythemia Vera*/genetics
Aged ; Alleles ; Female ; Humans ; Janus Kinase 2/genetics ; Male ; Mutation ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Variables associated with patient-reported outcomes in patients with myeloproliferative neoplasms.
Autorzy :
Shi D; Peking University People's Hospital, Beijing, China.
Shi H; Peking University People's Hospital, Beijing, China.
Liu X; Nanfang Hospital, Southern Medical University, Guangzhou, China.
Duan M; Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Zhuang J; Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Du X; Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen, China.
Qin L; The First Affiliated Hospital and College of Clinical Medicine of Henan University of Science and Technology, Henan, China.
Hui W; Xuanwu Hospital, Capital Medical University, Beijing, China.
Liang R; Xi Jing Hospital, The Fourth Military Medical University, Shanxi, China.
Wang M; Second Hospital of Shanxi Medical University, Shanxi, China.
Chen Y; Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Li D; Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
Yang W; Shengjing Hospital Affiliated to China Medical University, Shenyang, China.
Tang G; Changhai Hospital, Second Military Medical University, Shanghai, China.
Zhang W; First Hospital of Shanxi Medical University, Shanxi, China.
Kuang X; Kaifeng Central Hospital, Henan, China.
Su W; Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, China.
Han Y; The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China.
Chen L; The First Affiliated Hospital of Xi'an Jiaotong University, Shanxi, China.
Xu J; Qiqihar First Hospital, Heilongjiang, China.
Liu Z; Shengjing Hospital Affiliated to China Medical University, Shenyang, China.
Huang J; The Fourth Affiliated Hospital of Zhejiang University School of Medicine, Zhejiang, China.
Zhao C; The Affiliated Hospital of Qingdao University, Qingdao, China Shandong.
Tong H; The First Affiliated Hospital of College of Medicine, Zhejiang University, Zhejiang, China.
Hu J; Fujian Medical University Union Hospital, Fujian, China.
Chen C; Shandong University Qilu Hospital, Shandong, China.
Chen X; Institute of Hematology & Affiliated Hospital, Medicine School, Northwestern University, Shan'xi, China.
Xiao Z; Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.
Jiang Q; Peking University People's Hospital, Beijing, China.; Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China.
Pokaż więcej
Źródło :
Leukemia & lymphoma [Leuk Lymphoma] 2021 Nov; Vol. 62 (11), pp. 2703-2715. Date of Electronic Publication: 2021 Jun 08.
Typ publikacji :
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Myeloproliferative Disorders*/diagnosis
Myeloproliferative Disorders*/drug therapy
Myeloproliferative Disorders*/epidemiology
Polycythemia Vera*/diagnosis
Polycythemia Vera*/drug therapy
Polycythemia Vera*/epidemiology
Cross-Sectional Studies ; Humans ; Patient Reported Outcome Measures ; Quality of Life
Czasopismo naukowe
Tytuł :
Ruxolitinib-treated polycythemia vera patients and their risk of secondary malignancies.
Autorzy :
Sekhri R; University Clinic for Hematology, Oncology, Hemostaseology and Palliative Care, Johannes Wesling Medical Center Minden, University of Bochum, Hans-Nolte-Straße 1, 32429, Minden, Germany.
Sadjadian P; University Clinic for Hematology, Oncology, Hemostaseology and Palliative Care, Johannes Wesling Medical Center Minden, University of Bochum, Hans-Nolte-Straße 1, 32429, Minden, Germany.
Becker T; University Clinic for Hematology, Oncology, Hemostaseology and Palliative Care, Johannes Wesling Medical Center Minden, University of Bochum, Hans-Nolte-Straße 1, 32429, Minden, Germany.
Kolatzki V; University Clinic for Hematology, Oncology, Hemostaseology and Palliative Care, Johannes Wesling Medical Center Minden, University of Bochum, Hans-Nolte-Straße 1, 32429, Minden, Germany.
Huenerbein K; University Clinic for Hematology, Oncology, Hemostaseology and Palliative Care, Johannes Wesling Medical Center Minden, University of Bochum, Hans-Nolte-Straße 1, 32429, Minden, Germany.
Meixner R; Institute of Computational Biology, Helmholtz Center Munich, Ingolstädter Landstraße 1, 85764, Neuherberg, Germany.
Marchi H; Institute of Computational Biology, Helmholtz Center Munich, Ingolstädter Landstraße 1, 85764, Neuherberg, Germany.; Bielefeld University, Universitätsstraße, 25 33615, Bielefeld, Germany.
Wallmann R; University Clinic for Hematology, Oncology, Hemostaseology and Palliative Care, Johannes Wesling Medical Center Minden, University of Bochum, Hans-Nolte-Straße 1, 32429, Minden, Germany.
Fuchs C; Institute of Computational Biology, Helmholtz Center Munich, Ingolstädter Landstraße 1, 85764, Neuherberg, Germany.; Bielefeld University, Universitätsstraße, 25 33615, Bielefeld, Germany.
Griesshammer M; University Clinic for Hematology, Oncology, Hemostaseology and Palliative Care, Johannes Wesling Medical Center Minden, University of Bochum, Hans-Nolte-Straße 1, 32429, Minden, Germany.
Wille K; University Clinic for Hematology, Oncology, Hemostaseology and Palliative Care, Johannes Wesling Medical Center Minden, University of Bochum, Hans-Nolte-Straße 1, 32429, Minden, Germany. .
Pokaż więcej
Źródło :
Annals of hematology [Ann Hematol] 2021 Nov; Vol. 100 (11), pp. 2707-2716. Date of Electronic Publication: 2021 Aug 31.
Typ publikacji :
Journal Article
MeSH Terms :
Neoplasms, Second Primary/*chemically induced
Polycythemia Vera/*drug therapy
Pyrazoles/*adverse effects
Adult ; Aged ; Aged, 80 and over ; Female ; Follow-Up Studies ; Humans ; Hydroxyurea/adverse effects ; Hydroxyurea/therapeutic use ; Incidence ; Janus Kinase 2/genetics ; Lymphoma/chemically induced ; Lymphoma/epidemiology ; Male ; Middle Aged ; Mutation, Missense ; Neoplasms, Second Primary/epidemiology ; Polycythemia Vera/genetics ; Primary Myelofibrosis/chemically induced ; Primary Myelofibrosis/etiology ; Proportional Hazards Models ; Pyrazoles/therapeutic use ; Retrospective Studies ; Risk ; Skin Neoplasms/chemically induced ; Skin Neoplasms/epidemiology
Czasopismo naukowe
Tytuł :
Disseminated blastomycosis in a patient with polycythemia vera on ruxolitinib.
Autorzy :
Zeitler K; Department of Pharmacy, Tampa General Hospital, Tampa, Florida, USA.
Jariwala R; Department of Pharmacy, University of California San Francisco, San Francisco, California, USA.
Alrabaa S; Division of Infectious Diseases and International Medicine, Department of Internal Medicine, University of South Florida, Tampa, Florida, USA.
Sriaroon C; Pulmonary/Critical Care, University of South Florida, Tampa, Florida, USA .
Pokaż więcej
Źródło :
BMJ case reports [BMJ Case Rep] 2021 Nov 01; Vol. 14 (11). Date of Electronic Publication: 2021 Nov 01.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Blastomycosis*
Polycythemia Vera*/complications
Polycythemia Vera*/drug therapy
Primary Myelofibrosis*/complications
Primary Myelofibrosis*/drug therapy
Humans ; Nitriles ; Pyrazoles/therapeutic use ; Pyrimidines
Czasopismo naukowe
Tytuł :
Polycythemia vera complicated by chorea: A case report and the review of Chinese and international literature.
Autorzy :
Raza HK; Department of Neurology, the Affiliated Hospital of Xuzhou Medical University, 221002 Xuzhou, China; School of International Education, Xuzhou Medical University, 221002 Xuzhou, China.
Chansysouphanthong T; School of International Education, Xuzhou Medical University, 221002 Xuzhou, China.
Singh S; School of International Education, Xuzhou Medical University, 221002 Xuzhou, China.
Amir A; Central Park Medical College, Lahore, Pakistan.
Raza MW; Hainan University, Haikou, Hainan, China.
Zhang Z; Department of Neurology, the Affiliated Hospital of Xuzhou Medical University, 221002 Xuzhou, China.
Cui G; Department of Neurology, the Affiliated Hospital of Xuzhou Medical University, 221002 Xuzhou, China. Electronic address: .
Chen H; Department of Neurology, the Affiliated Hospital of Xuzhou Medical University, 221002 Xuzhou, China. Electronic address: .
Pokaż więcej
Źródło :
Revue neurologique [Rev Neurol (Paris)] 2021 Oct; Vol. 177 (8), pp. 1025-1030. Date of Electronic Publication: 2021 Mar 26.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Chorea*/diagnosis
Chorea*/etiology
Polycythemia Vera*/complications
Polycythemia Vera*/diagnosis
China ; Humans
Czasopismo naukowe
Tytuł :
Evaluation of the need for cytoreduction and its potential carcinogenicity in children and young adults with myeloproliferative neoplasms.
Autorzy :
Choi HS; Department of Pediatrics, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
Hong J; Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
Hwang SM; Department of Laboratory, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
Lee JH; Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, 82 Gumi-ro, 173 Beon-gil, Bundang-gu, Seongnam-si, 13620, Gyeonggi-do, Republic of Korea.
Ma Y; Department of Pediatrics, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
Kim SA; Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, 82 Gumi-ro, 173 Beon-gil, Bundang-gu, Seongnam-si, 13620, Gyeonggi-do, Republic of Korea.
Lee JY; Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, 82 Gumi-ro, 173 Beon-gil, Bundang-gu, Seongnam-si, 13620, Gyeonggi-do, Republic of Korea.
Lee JO; Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, 82 Gumi-ro, 173 Beon-gil, Bundang-gu, Seongnam-si, 13620, Gyeonggi-do, Republic of Korea.
Bang SM; Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, 82 Gumi-ro, 173 Beon-gil, Bundang-gu, Seongnam-si, 13620, Gyeonggi-do, Republic of Korea. .
Pokaż więcej
Źródło :
Annals of hematology [Ann Hematol] 2021 Oct; Vol. 100 (10), pp. 2567-2574. Date of Electronic Publication: 2021 Jul 30.
Typ publikacji :
Journal Article
MeSH Terms :
Antineoplastic Agents/*therapeutic use
Hydroxyurea/*therapeutic use
Neoplasms, Second Primary/*etiology
Polycythemia Vera/*drug therapy
Thrombocythemia, Essential/*drug therapy
Adolescent ; Adult ; Antineoplastic Agents/adverse effects ; Aspirin/therapeutic use ; Child ; Female ; Fibrinolytic Agents/therapeutic use ; Follow-Up Studies ; Humans ; Hydroxyurea/adverse effects ; Leukemia/etiology ; Male ; Polycythemia Vera/complications ; Primary Myelofibrosis/etiology ; Thrombocythemia, Essential/complications ; Thromboembolism/drug therapy ; Thromboembolism/etiology ; Young Adult
Czasopismo naukowe
Tytuł :
Cutaneous ulceration as primary presentation of TEMPI syndrome.
Autorzy :
Strobl J; Department of Dermatology, Medical University of Vienna, Vienna, Austria.
Sinz C; Department of Dermatology, Medical University of Vienna, Vienna, Austria.
Heil PM; Department of Dermatology, Medical University of Vienna, Vienna, Austria.
Stary G; Department of Dermatology, Medical University of Vienna, Vienna, Austria.; Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases, Vienna, Austria.
Weninger W; Department of Dermatology, Medical University of Vienna, Vienna, Austria.
Pokaż więcej
Źródło :
Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2021 Dec; Vol. 35 (12), pp. e891-e894. Date of Electronic Publication: 2021 Aug 04.
Typ publikacji :
Letter
MeSH Terms :
Paraproteinemias*
Polycythemia*
Telangiectasis*
Humans
Opinia redakcyjna
Tytuł :
[Clinical Characteristics of Patients with JAK2 Gene Mutation Myeloproliferative Neoplasms].
Autorzy :
Li YJ; Department of Hematology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China.
Zhu SR; Department of Hematology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China,Beijing University of Chinese Medicine, Beijing 100029, China.
Liu WY; Department of Hematology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China.
Ming J; Department of Hematology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China.
Wang ZQ; Department of Hematology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China,Beijing University of Chinese Medicine, Beijing 100029, China.
Zhang SS; Department of Hematology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China,E-mail:.
Hu XM; Department of Hematology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China,E-mail: .
Pokaż więcej
Źródło :
Zhongguo shi yan xue ye xue za zhi [Zhongguo Shi Yan Xue Ye Xue Za Zhi] 2021 Oct; Vol. 29 (5), pp. 1533-1539.
Typ publikacji :
Journal Article
MeSH Terms :
Myeloproliferative Disorders*/genetics
Polycythemia Vera*
Humans ; Janus Kinase 2/genetics ; Mutation Rate ; Retrospective Studies
Czasopismo naukowe
Tytuł :
[Analysis of Clinical Characteristics of JAK2 V617F and BCR-ABL Double-Mutant Myeloproliferative Neoplasms].
Autorzy :
Yan J; Department of Hematology,The Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, Hebei Province, China.
Ding YW; Cinical Laboratory, The Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, Hebei Province, China.
Wang PY; Cinical Laboratory, The Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, Hebei Province, China.
Wu YP; Cinical Laboratory, The Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, Hebei Province, China.
Zhang HC; Cinical Laboratory, The Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, Hebei Province, China. E-mail: .
Liu LH; Department of Hematology,The Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, Hebei Province, China. E-mail: .
Pokaż więcej
Źródło :
Zhongguo shi yan xue ye xue za zhi [Zhongguo Shi Yan Xue Ye Xue Za Zhi] 2021 Oct; Vol. 29 (5), pp. 1540-1547.
Typ publikacji :
Journal Article
MeSH Terms :
Myeloproliferative Disorders*/genetics
Polycythemia Vera*
Thrombocythemia, Essential*
Adult ; Aged ; Aged, 80 and over ; Female ; Fusion Proteins, bcr-abl/genetics ; Humans ; Janus Kinase 2/genetics ; Male ; Middle Aged ; Young Adult
Czasopismo naukowe
Tytuł :
Gaisbock's Syndrome: A Case Study.
Autorzy :
Rao S; Consultant Physician, Department of Internal Medicine, Department of Internal Medicine, Manipal Hospital, Bangalore, Karnataka.
Kalashetty M; Consultant Hematologist, Department of Hematology, Department of Internal Medicine, Manipal Hospital, Bangalore, Karnataka.
Venkateswarlu D; Resident (DNB), Department of Internal Medicine, Manipal Hospital, Bangalore, Karnataka.
Pokaż więcej
Źródło :
The Journal of the Association of Physicians of India [J Assoc Physicians India] 2021 Sep; Vol. 69 (9), pp. 11-12.
Typ publikacji :
Journal Article
MeSH Terms :
Hypertension*
Polycythemia*/etiology
Polycythemia Vera*/complications
Polycythemia Vera*/diagnosis
Aged ; Humans ; Male
Czasopismo naukowe
Tytuł :
Thrombotic and hemorrhagic events in 2016 World Health Organization-defined Philadelphia-negative myeloproliferative neoplasm.
Autorzy :
Song IC; Division of Hematology/Oncology, Department of Internal Medicine, Chungnam National University College of Medicine, Daejeon, Korea.
Yeon SH; Division of Hematology/Oncology, Department of Internal Medicine, Chungnam National University College of Medicine, Daejeon, Korea.
Lee MW; Division of Hematology/Oncology, Department of Internal Medicine, Chungnam National University College of Medicine, Daejeon, Korea.
Ryu H; Division of Hematology/Oncology, Department of Internal Medicine, Chungnam National University College of Medicine, Daejeon, Korea.
Lee HJ; Division of Hematology/Oncology, Department of Internal Medicine, Chungnam National University College of Medicine, Daejeon, Korea.
Yun HJ; Division of Hematology/Oncology, Department of Internal Medicine, Chungnam National University College of Medicine, Daejeon, Korea.
Kim SY; Department of Laboratory Medicine, Chungnam National University College of Medicine, Daejeon, Korea.
Jo DY; Division of Hematology/Oncology, Department of Internal Medicine, Chungnam National University College of Medicine, Daejeon, Korea.
Pokaż więcej
Źródło :
The Korean journal of internal medicine [Korean J Intern Med] 2021 Sep; Vol. 36 (5), pp. 1190-1203. Date of Electronic Publication: 2021 Jul 22.
Typ publikacji :
Journal Article
MeSH Terms :
Myeloproliferative Disorders*/diagnosis
Myeloproliferative Disorders*/epidemiology
Polycythemia Vera*/diagnosis
Polycythemia Vera*/epidemiology
Thrombosis*/epidemiology
Thrombosis*/etiology
Female ; Humans ; Male ; Middle Aged ; Retrospective Studies ; World Health Organization
Czasopismo naukowe
Tytuł :
Clinical outcomes of interferon therapy for polycythemia vera and essential thrombocythemia: a systematic review and meta-analysis.
Autorzy :
Gu W; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.; Center for Stem Cell Medicine, Chinese Academy of Medical Sciences, Tianjin, 300020, China.; Department of Stem Cell & Regenerative Medicine, Peking Union Medical College, Tianjin, 300020, China.; CAMS Key Laboratory of Gene Therapy for Blood Diseases, Tianjin, 300020, China.; Tianjin Key Laboratory of Gene Therapy for Blood Diseases, Tianjin, 300020, China.
Yang R; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.; Center for Stem Cell Medicine, Chinese Academy of Medical Sciences, Tianjin, 300020, China.; Department of Stem Cell & Regenerative Medicine, Peking Union Medical College, Tianjin, 300020, China.; CAMS Key Laboratory of Gene Therapy for Blood Diseases, Tianjin, 300020, China.; Tianjin Key Laboratory of Gene Therapy for Blood Diseases, Tianjin, 300020, China.
Xiao Z; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.; Center for Stem Cell Medicine, Chinese Academy of Medical Sciences, Tianjin, 300020, China.; Department of Stem Cell & Regenerative Medicine, Peking Union Medical College, Tianjin, 300020, China.
Zhang L; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China. .; Center for Stem Cell Medicine, Chinese Academy of Medical Sciences, Tianjin, 300020, China. .; Department of Stem Cell & Regenerative Medicine, Peking Union Medical College, Tianjin, 300020, China. .; CAMS Key Laboratory of Gene Therapy for Blood Diseases, Tianjin, 300020, China. .; Tianjin Key Laboratory of Gene Therapy for Blood Diseases, Tianjin, 300020, China. .
Pokaż więcej
Źródło :
International journal of hematology [Int J Hematol] 2021 Sep; Vol. 114 (3), pp. 342-354. Date of Electronic Publication: 2021 Jun 06.
Typ publikacji :
Journal Article; Meta-Analysis; Systematic Review
MeSH Terms :
Interferons/*therapeutic use
Polycythemia Vera/*drug therapy
Thrombocythemia, Essential/*drug therapy
Biomarkers ; Cell Transformation, Neoplastic ; Disease Management ; Disease Progression ; Hematologic Tests ; Humans ; Interferons/pharmacology ; Polycythemia Vera/diagnosis ; Polycythemia Vera/etiology ; Prognosis ; Publication Bias ; Thrombocythemia, Essential/diagnosis ; Thrombocythemia, Essential/etiology ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Diagnosis and management of non-clonal erythrocytosis remains challenging: a single centre clinical experience.
Autorzy :
Anžej Doma S; Department of Haematology, University Medical Centre Ljubljana, Zaloška 7, 1000, Ljubljana, Slovenia.; Faculty of Medicine, University of Ljubljana, Korytkova 2, 1000, Ljubljana, Slovenia.
Drnovšek E; Department of Haematology, University Medical Centre Ljubljana, Zaloška 7, 1000, Ljubljana, Slovenia.; Medical Centre for Molecular Biology, Institute of Biochemistry and Molecular Genetics, Faculty of Medicine, University of Ljubljana, Vrazov trg 2, 1000, Ljubljana, Slovenia.
Kristan A; Medical Centre for Molecular Biology, Institute of Biochemistry and Molecular Genetics, Faculty of Medicine, University of Ljubljana, Vrazov trg 2, 1000, Ljubljana, Slovenia.
Fink M; Department of Haematology, University Medical Centre Ljubljana, Zaloška 7, 1000, Ljubljana, Slovenia.
Sever M; Department of Haematology, University Medical Centre Ljubljana, Zaloška 7, 1000, Ljubljana, Slovenia.; Faculty of Medicine, University of Ljubljana, Korytkova 2, 1000, Ljubljana, Slovenia.
Podgornik H; Department of Haematology, University Medical Centre Ljubljana, Zaloška 7, 1000, Ljubljana, Slovenia.; Faculty of Pharmacy, University of Ljubljana, Aškerčeva 7, 1000, Ljubljana, Slovenia.
Belčič Mikič T; Department of Haematology, University Medical Centre Ljubljana, Zaloška 7, 1000, Ljubljana, Slovenia.; Faculty of Medicine, University of Ljubljana, Korytkova 2, 1000, Ljubljana, Slovenia.
Debeljak N; Medical Centre for Molecular Biology, Institute of Biochemistry and Molecular Genetics, Faculty of Medicine, University of Ljubljana, Vrazov trg 2, 1000, Ljubljana, Slovenia.
Preložnik Zupan I; Department of Haematology, University Medical Centre Ljubljana, Zaloška 7, 1000, Ljubljana, Slovenia. .; Faculty of Medicine, University of Ljubljana, Korytkova 2, 1000, Ljubljana, Slovenia. .
Pokaż więcej
Źródło :
Annals of hematology [Ann Hematol] 2021 Aug; Vol. 100 (8), pp. 1965-1973. Date of Electronic Publication: 2021 May 19.
Typ publikacji :
Journal Article
MeSH Terms :
Polycythemia/*diagnosis
Polycythemia/*therapy
Adult ; Disease Management ; Female ; High-Throughput Nucleotide Sequencing ; Humans ; Male ; Middle Aged ; Phlebotomy ; Polycythemia/congenital ; Polycythemia/genetics ; Retrospective Studies
Czasopismo naukowe
Tytuł :
The active ingredients and mechanisms of Longchai Jiangxue Formula in treating PV, based on UPLC/Q-TOF-MS/MS, systematic pharmacology, and molecular biology validation.
Autorzy :
Ming J; Department of Hematology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China; Postdoctoral Research Programme of China Academy of Chinese Medical Sciences, Beijing 100700, China. Electronic address: .
Liu W; Department of Hematology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China. Electronic address: .
Wu H; Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing100700, China. Electronic address: .
Li Y; Department of Hematology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China; Graduate School, China Academy of Chinese Medical Sciences, Beijing 100700, China. Electronic address: .
Yang E; Department of Hematology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China; Graduate School, China Academy of Chinese Medical Sciences, Beijing 100700, China. Electronic address: .
Wang Z; Department of Hematology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China; Graduate School, Beijing University of Chinese Medicine, Beijing 100029, China. Electronic address: .
Xiao H; Department of Hematology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China. Electronic address: .
Quan R; Department of Hematology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China. Electronic address: .
Hu X; Department of Hematology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China. Electronic address: .
Pokaż więcej
Źródło :
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2021 Aug; Vol. 140, pp. 111767. Date of Electronic Publication: 2021 May 28.
Typ publikacji :
Journal Article
MeSH Terms :
Drugs, Chinese Herbal/*chemistry
Drugs, Chinese Herbal/*pharmacology
Polycythemia Vera/*drug therapy
Apoptosis/drug effects ; Cell Line, Tumor ; Cell Survival/drug effects ; Chromatography, High Pressure Liquid ; Humans ; Molecular Docking Simulation ; Phytochemicals/analysis ; Phytochemicals/pharmacology ; Polycythemia Vera/genetics ; Polycythemia Vera/metabolism ; Protein Interaction Maps ; Tandem Mass Spectrometry
Czasopismo naukowe
Tytuł :
Prevalence of unexplained erythrocytosis and thrombocytosis - an NHANES analysis.
Autorzy :
Tremblay D; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Alpert N; Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Taioli E; Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Mascarenhas J; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Pokaż więcej
Źródło :
Leukemia & lymphoma [Leuk Lymphoma] 2021 Aug; Vol. 62 (8), pp. 2030-2033. Date of Electronic Publication: 2021 Feb 28.
Typ publikacji :
Letter
MeSH Terms :
Polycythemia*/diagnosis
Polycythemia*/epidemiology
Polycythemia Vera*
Thrombocytosis*/diagnosis
Thrombocytosis*/epidemiology
Humans ; Nutrition Surveys ; Prevalence
Opinia redakcyjna
Tytuł :
Polycythaemia vera: molecular genetics, diagnostics and therapeutics.
Autorzy :
Putter JS; Medical Biomechanics Inc., North San Diego County, San Marcos, CA, USA.
Seghatchian J; International Consultancy in Innovative Manufacturing and Quality/Safety of Blood - Derived Bioproducts, London, UK.
Pokaż więcej
Źródło :
Vox sanguinis [Vox Sang] 2021 Jul; Vol. 116 (6), pp. 617-627. Date of Electronic Publication: 2021 Feb 26.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Polycythemia Vera*/diagnosis
Polycythemia Vera*/genetics
Polycythemia Vera*/therapy
Thrombosis*
Humans ; Janus Kinase 2/genetics ; Molecular Biology ; Mutation
Czasopismo naukowe
Tytuł :
A novel bone marrow-sparing treatment for primary erythrocytosis in a cat: Onion powder.
Autorzy :
Vasilatis DM; University of California-Davis, School of Veterinary Medicine, William R. Pritchard Veterinary Medical Teaching Hospital, Davis, California, USA.
McGill JE; University of California-Davis, School of Veterinary Medicine, William R. Pritchard Veterinary Medical Teaching Hospital, Davis, California, USA.
Gilor C; Department of Veterinary Medicine and Epidemiology, University of California, Davis, California, USA.; Department of Small Animal Clinical Sciences, College of Veterinary Medicine, University of Florida, Gainesville, Florida, USA.
Pokaż więcej
Źródło :
Journal of veterinary internal medicine [J Vet Intern Med] 2021 Jul; Vol. 35 (4), pp. 1977-1980. Date of Electronic Publication: 2021 Jun 10.
Typ publikacji :
Case Reports
MeSH Terms :
Cat Diseases*/drug therapy
Polycythemia*/drug therapy
Polycythemia*/veterinary
Animals ; Bone Marrow ; Cats ; Onions ; Powders ; Prospective Studies
Raport

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies